Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Jan 2001 10:00 AM
RNS
Director Shareholding
22 Dec 2000 01:17 PM
RNS
TaoTalk Investment ceases
18 Dec 2000 04:20 PM
RNS
Additional Listing
12 Dec 2000 07:00 AM
RNS
Re Alliance
24 Nov 2000 07:00 AM
RNS
Director Shareholding
23 Nov 2000 07:00 AM
RNS
Strategic Investment
14 Sep 2000 07:00 AM
RNS
Strategic Telecoms Investment
07 Sep 2000 07:01 AM
RNS
Strategic Alliance
22 Aug 2000 07:00 AM
RNS
Change to Board of Directors
22 Aug 2000 07:00 AM
RNS
Strategic Investment
22 Aug 2000 07:00 AM
RNS
Interim Results
16 Aug 2000 12:42 PM
RNS
Advance Notice of Interim Results
10 Aug 2000 10:15 AM
RNS
Acquisition of Interest
13 Jun 2000 10:44 AM
RNS
New Strategic Investment
15 May 2000 07:00 AM
RNS
Strategic Investment
09 May 2000 07:01 AM
RNS
£1.5m Deal Signed with Harden's Ltd
10 Apr 2000 07:01 AM
RNS
£300,000 Investment for 25% of Mailtrack Ltd
29 Feb 2000 02:58 PM
RNS
Directorate, etc

ValiRx is a fast-growing drug development company focused on identifying novel science with high potential for successful development into products that improve the lives of patients throughout treatment.

ValiRx share price listed on AIM in 2004 under the ticker VAL.

UK 100

Latest directors dealings